Seguir
Mattia Galli
Mattia Galli
Assistant Professor, Cardiology; Sapienza University of Rome, Italy
Dirección de correo verificada de uniroma1.it
Título
Citado por
Citado por
Año
Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
M Galli, S Benenati, D Capodanno, F Franchi, F Rollini, D D'Amario, ...
The Lancet 397 (10283), 1470-1483, 2021
2082021
Antiplatelet therapy after percutaneous coronary intervention
DJ Angiolillo, M Galli, JP Collet, A Kastrati, ML O'Donoghue
EuroIntervention 17 (17), e1371, 2022
1752022
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials
M Galli, S Benenati, F Franchi, F Rollini, D Capodanno, G Biondi-Zoccai, ...
European heart journal 43 (10), 959-967, 2022
1452022
Microvascular dysfunction in heart failure with preserved ejection fraction
D D’Amario, S Migliaro, JA Borovac, A Restivo, R Vergallo, M Galli, ...
Frontiers in physiology 10, 1347, 2019
1212019
Coronary atherosclerotic phenotype and plaque healing in patients with recurrent acute coronary syndromes compared with patients with long-term clinical stability: an in vivo …
R Vergallo, I Porto, D D’Amario, G Annibali, M Galli, S Benenati, ...
JAMA cardiology 4 (4), 321-329, 2019
1192019
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs
G Patti, I Cavallari, F Andreotti, P Calabro, P Cirillo, G Denas, M Galli, ...
Nature Reviews Cardiology 16 (2), 113-130, 2019
1032019
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis …
L Ortega-Paz, M Galli, D Capodanno, F Franchi, F Rollini, B Bikdeli, ...
European Heart Journal-Cardiovascular Pharmacotherapy 8 (7), 677-686, 2022
732022
Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge
JA Borovac, D D’Amario, R Vergallo, I Porto, A Bisignani, M Galli, ...
European Heart Journal–Cardiovascular Pharmacotherapy 5 (2), 105-116, 2019
652019
Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta-analysis of …
S Benenati, M Galli, V De Marzo, F Pescetelli, M Toma, F Andreotti, ...
European Heart Journal-Cardiovascular Pharmacotherapy 7 (2), 86-93, 2021
592021
Intracranial haemorrhages vs. stent thromboses with direct oral anticoagulant plus single antiplatelet agent or triple antithrombotic therapy: a meta-analysis of randomized …
M Galli, F Andreotti, I Porto, F Crea
EP Europace 22 (4), 538-546, 2020
532020
Management of coronary artery disease in older adults: recent advances and gaps in evidence
S Cacciatore, L Spadafora, M Bernardi, M Galli, M Betti, F Perone, ...
Journal of clinical medicine 12 (16), 5233, 2023
442023
Role of platelet function and genetic testing in patients undergoing percutaneous coronary intervention
M Galli, F Franchi, F Rollini, DJ Angiolillo
Trends in cardiovascular medicine 33 (3), 133-138, 2023
422023
Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations
M Galli, F Franchi, F Rollini, LH Cavallari, D Capodanno, F Crea, ...
Expert review of clinical pharmacology 14 (8), 963-978, 2021
422021
Where does inflammation fit?
LM Biasucci, G La Rosa, D Pedicino, A D’Aiello, M Galli, G Liuzzo
Current cardiology reports 19, 1-10, 2017
422017
Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction
M Galli, G Niccoli, G De Maria, S Brugaletta, RA Montone, R Vergallo, ...
Nature Reviews Cardiology 21 (5), 283-298, 2024
412024
Colchicine in ischemic heart disease: the good, the bad and the ugly
D D’Amario, D Cappetta, L Cappannoli, G Princi, S Migliaro, G Diana, ...
Clinical research in cardiology 110, 1531-1542, 2021
412021
Factor XI inhibitors in early clinical trials: a meta-analysis
M Galli, R Laborante, L Ortega-Paz, F Franchi, F Rollini, D D'Amario, ...
Thrombosis and Haemostasis 123 (06), 576-584, 2023
392023
Precision medicine in interventional cardiology: implications for antiplatelet therapy in patients undergoing percutaneous coronary intervention
M Galli, L Ortega-Paz, F Franchi, F Rollini, DJ Angiolillo
Pharmacogenomics 23 (13), 723-737, 2022
362022
De-escalation of antiplatelet therapy in acute coronary syndromes: why, how and when?
M Galli, DJ Angiolillo
Frontiers in cardiovascular medicine 9, 975969, 2022
352022
Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: a systematic review and meta-analysis
M Galli, F Andreotti, D D’Amario, R Vergallo, GM Vescovo, L Giraldi, ...
European Heart Journal-Cardiovascular Pharmacotherapy 6 (1), 43-56, 2020
342020
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20